Recent FDA Guidance Documents on Manufacturer Communications about Medical Products

Quantity

Back to Results

Recorded March 16, 2017 | On-Demand Webinar

In light of FDA’s recent public hearing on off-label communications, on January 18, FDA released two draft guidance documents and one memorandum to address FDA’s current thoughts on communicating health care economic information to payors, consistent-with-label communications, and communications regarding unapproved uses of approved medical products.
Do these documents illustrate a change of course for FDA, indicate a path for the future, or leave unanswered questions?
What are the First Amendment implications?
This webinar will discuss these questions, as well as insights on how these two draft guidance documents might be implemented and the potential effect for drug and medical device companies. The draft guidance documents are open for comment until April 19, 2017.

IE and Edge users: Microsoft Internet Explorer (IE) and Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you in your purchase.

Assign Members :

Members Assigned | Assign all contacts Unassign all contacts

Add New Contact

Assign	Full Name	Account Name	Email	Role

Total Records - Showing Page

Add New Contact

Discounts and special pricing for additional items will be applied once you add the item to your cart.